| Dr Sheldon Newman, MD | |
|
27005 76th Ave, New Hyde Park, NY 11040-1433 | |
| (718) 470-7390 | |
| Not Available |
| Full Name | Dr Sheldon Newman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 27005 76th Ave, New Hyde Park, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033115282 | NPI | - | NPPES |
| 01586369 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 194799 (New York) | Primary |
| Entity Name | North American Partners In Anesthesia Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649264706 PECOS PAC ID: 7719885771 Enrollment ID: O20040108000176 |
News Archive
As the Senate Finance Committee writes incentive bonuses for IT into the new "America's Healthy Future Act" reform bill, there already exists a fast-growing roster of vendors and healthcare organizations delivering mobile applications that make health management more efficient, accessible, and cost-effective for the shared benefit of physicians, healthcare providers and consumers alike.
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania in a plenary session during the American Society of Clinical Oncology's annual meeting.
Vermillion, Inc., a molecular diagnostics company, today announced that it is relocating its corporate headquarters from Fremont, California to Austin, Texas. Vermillion has executed a two-year lease for a new principal place of business at 12117 Bee Cave Road, Building Two, Suite 100, Austin, TX 78731. Vermillion will continue to operate research and development, regulatory and quality operations in California. All other functions will be conducted at the Austin offices.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sheldon Newman, MD 68 S Service Rd, Suite 350, Melville, NY 11747-2354 Ph: (516) 945-3000 | Dr Sheldon Newman, MD 27005 76th Ave, New Hyde Park, NY 11040-1433 Ph: (718) 470-7390 |
News Archive
As the Senate Finance Committee writes incentive bonuses for IT into the new "America's Healthy Future Act" reform bill, there already exists a fast-growing roster of vendors and healthcare organizations delivering mobile applications that make health management more efficient, accessible, and cost-effective for the shared benefit of physicians, healthcare providers and consumers alike.
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania in a plenary session during the American Society of Clinical Oncology's annual meeting.
Vermillion, Inc., a molecular diagnostics company, today announced that it is relocating its corporate headquarters from Fremont, California to Austin, Texas. Vermillion has executed a two-year lease for a new principal place of business at 12117 Bee Cave Road, Building Two, Suite 100, Austin, TX 78731. Vermillion will continue to operate research and development, regulatory and quality operations in California. All other functions will be conducted at the Austin offices.
› Verified 8 days ago
Dr. Brian Walrath Nicholas, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2800 Marcus Ave Ste 108, New Hyde Park, NY 11042 Phone: 516-622-7400 | |
Dr. Liborio Carmine Musacchia, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Rd, New Hyde Park, NY 11042 Phone: 631-988-6733 | |
Benjamin Marsh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 26901 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-3000 | |
Dr. Ellen Kavee, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-7390 | |
Dr. Richard Krauss, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-7390 | |
Dr. Barry Cohen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2800 Marcus Ave, New Hyde Park, NY 11042 Phone: 516-622-6000 |